Fabregas, Jesus C.
Carter, Benjamin T.
Lutzky, Jose
Robinson, William Russell III
Brant, Jeannine M. http://orcid.org/0000-0001-6654-739X
Article History
Received: 15 July 2021
Revised: 28 September 2021
Accepted: 1 October 2021
First Online: 14 October 2021
Declarations
:
: This data-only study was approved with waiver of consent by the Billings Clinic Institutional Review Board.
: Not applicable.
: Not applicable.
: Authors Jesus C. Fabregas, Benjamin T. Carter, and William Russell Robinson, III, have no financial interests to disclose. Jose Lutzky reported consulting or advisory roles for Castle Biosciences, Iovance Biotherapeutics, Replimune, and Regeneron. Jeannine M. Brant reported serving on the Speakers’ Bureau for Daiichi Sankyo/Astra Zeneca.